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Background. Meta-analyses show that cognitive behaviour therapy for psychosis (CBT-P) improves distressing
positive symptoms. However, it is a complex intervention involving a range of techniques. No previous study has
assessed the delivery of the diﬀerent elements of treatment and their eﬀect on outcome. Our aim was to assess the
diﬀerential eﬀect of type of treatment delivered on the eﬀectiveness of CBT-P, using novel statistical methodology.
Method. The Psychological Prevention of Relapse in Psychosis (PRP) trial was a multi-centre randomized controlled
trial (RCT) that compared CBT-P with treatment as usual (TAU). Therapy was manualized, and detailed evaluations
of therapy delivery and client engagement were made. Follow-up assessments were made at 12 and 24 months. In a
planned analysis, we applied principal stratiﬁcation (involving structural equation modelling with ﬁnite mixtures) to
estimate intention-to-treat (ITT) eﬀects for subgroups of participants, deﬁned by qualitative and quantitative
diﬀerences in receipt of therapy, while maintaining the constraints of randomization.
Results. Consistent delivery of full therapy, including speciﬁc cognitive and behavioural techniques, was associated
with clinically and statistically signiﬁcant increases in months in remission, and decreases in psychotic and aﬀective
symptoms. Delivery of partial therapy involving engagement and assessment was not eﬀective.
Conclusions. Our analyses suggest that CBT-P is of signiﬁcant beneﬁt on multiple outcomes to patients able to
engage in the full range of therapy procedures. The novel statistical methods illustrated in this report have general
application to the evaluation of heterogeneity in the eﬀects of treatment.
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Introduction
The pharmacological treatment of positive symptoms
of psychosis is only moderately successful (Leucht
et al. 2009). Cognitive behaviour therapy for psychosis
(CBT-P) consistently reduces psychotic symptoms in
people with distressing medication-resistant symp-
toms, although average eﬀect sizes are fairly small
(Pilling et al. 2002 ; Jones et al. 2004 ; Zimmerman et al.
2005 ; Wykes et al. 2008). National Institute of Clinical
and Health Excellence updated guidelines for schizo-
phrenia recommend CBT-P (NICE, 2009).
The Psychological Prevention of Relapse in
Psychosis (PRP) trial was designed to evaluate the
eﬀectiveness of CBT-P in reducing relapse and im-
proving symptoms. The PRP trial compared CBT-P
and family intervention (FI) with treatment as usual
(TAU), and is fully described elsewhere (Garety et al.
2008). Intention-to-treat (ITT) analysis found no ben-
eﬁts for the primary outcomes of relapse and days in
hospital or for reduction in psychotic symptoms, but
did ﬁnd a signiﬁcant improvement in depression
(Garety et al. 2008). The trial manual describes cogni-
tive and behavioural techniques targeting the various
symptoms and problems presented by individuals.
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ORIGINAL ARTICLE
Therapists shape the techniques to the particular
problems that emerge during therapy (Fowler et al.
1995). Therapy therefore varies widely, being tailored
to the individual needs of a heterogeneous group of
clients with diﬀering levels of capacity and willing-
ness to engage.
However, CBT-P has so far only been evaluated as
an overall package. We lack information about the
delivery of diﬀerent therapeutic techniques, given that
clients may not be ready or able to countenance par-
ticular interactions (Durham et al. 2003). Single case
studies have suggested that it is the more active tech-
niques that lead to symptomatic changes, rather than
the necessary but preliminary stage of relationship
building and assessment (Fowler & Morley, 1989 ;
Chadwick et al. 2003).
The present study investigates how far competent
CBT therapists were able to deliver diﬀerent types of
therapy techniques, and the impact this has on eﬃ-
cacy. Reliable methods for monitoring therapeutic
delivery in CBT-P allow us to examine its relationship
with outcome (Startup et al. 2002 ; Durham et al. 2003 ;
Rollinson et al. 2007, 2008). Based on our cognitive
model (Garety et al. 2001), we hypothesized that out-
comes would be improved when therapists were able
to deliver the more speciﬁc cognitive and behavioural
techniques.
A key feature of this study is our novel statistical
approach for analysing diﬀerential eﬃcacy in random-
ized trials, informed by increasing recognition of the
biases and confounding inherent in past attempts at
post-hoc estimation of outcomes in relation to aspects
of therapeutic quality (Dunn & Bentall, 2007). The new
approach estimates ITT eﬀects for subgroups by com-
paring the eﬀects of intervention with putative eﬀects
in the control arms ignored in traditional analyses. The
evaluation of diﬀerential eﬃcacy of CBT-P techniques
formed part of the original protocol.
Method
Settings
The trial took place in ﬁve mental health services : two
in inner-city London, one in suburban outer London,
one in a provincial city (Norwich), and one in a rural
area (Norfolk).
Study design
The PRP trial comprised two pathways with separate
randomization, stratiﬁed within the ﬁve participating
centres, and within in-patient or out-patient status at
induction. The ﬁrst (‘ individual pathway’) included
participants without carers randomly allocated to two
groups : both received good standard care (treatment
as usual, TAU) whereas the experimental group
also received CBT-P. In the second pathway (‘carer
pathway’), those with carers were allocated to three
groups : CBT-P plus TAU, FI plus TAU, or TAU alone.
The current analysis is restricted to hypotheses con-
cerning CBT-P only, so the FI participants were
excluded.
Participants
We approached consecutive patients with recent
relapses, whether or not they had been admitted.
They were invited to take part once they could give
informed consent. The inclusion criteria were : current
clinical diagnosis of non-aﬀective psychosis (F2:
ICD-10 ; WHO, 1992; DSM-IV; APA, 1994) ; age
18–65 years ; a second or subsequent psychotic episode
starting not more than 3 months before induction; and
a rating of at least 4 (moderate severity) for at least one
positive symptom on the Positive and Negative
Syndrome Scale (PANSS; Kay, 1991). Exclusion cri-
teria were : a primary diagnosis of alcohol or substance
dependency, organic syndrome or learning disability ;
spoken English inadequate for engaging in psycho-
logical therapy; and unstable residential arrange-
ments.
Participants provided informed consent under pro-
tocols approved by the appropriate ethics committees.
Full details of the trial protocol are provided else-
where (Garety et al. 2008). Participants were assessed
at baseline before randomization, and at 3, 6, 12
and 24 months. The CBT-P was completed within
12 months whereas TAU continued throughout.
Treatment
CBT-P was delivered for 9 months, with a planned
minimum of 12 and a maximum of 20 sessions. The
therapy in our generic CBT-P manual (Fowler et al.
1995) was augmented with speciﬁc relapse prevention
techniques.
Therapy provision
One hundred and thirty-three people were allocated to
CBT-P. They received a mean of 14.3 sessions
(S.D.=7.8), each lasting on average 1 h. The number of
sessions was very similar in the individual and carer
arms.
Trial therapists : training and monitoring of
adherence and competence
Five lead trial therapists (‘ lead therapists ’), all
doctorate level or equivalent clinical psychologists
employed full time on the trial, provided therapy to
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96 CBT-P participants. A further 37 CBT-P participants
were seen by therapists employed by the National
Health Service (NHS) Trusts running the local mental
health services (‘ trust therapists ’). The trust therapists
were doctoral clinical psychologists and nurses with
specialist training in CBT-P. All were fully trained
and closely managed and supervised; details of re-
cruitment, training and quality control are provided
elsewhere (Garety et al. 2008). The Revised Cognitive
Therapy for Psychosis Adherence Scale (R-CTPAS;
Rollinson et al. 2008) is a measure of ﬁdelity, designed
to provide precise deﬁnitions of the minimum thera-
peutic delivery of CBT-P activity. It covers 21 diﬀerent
types of CBT-P techniques. Therapist competence
was measured by the Cognitive Therapy Scales (CTS;
Young & Beck, 1980). All raters were trained to cri-
terion on this scale and met regularly to check rating
reliability. A total of 185 tapes from 66 therapy par-
ticipants (62% of the total treated) were sent for formal
monitoring by the lead therapists from other centres.
In 90% of the sample, the CBT-P delivered in taped
interviews was both adherent and competent. In eight
cases (8.3%), the therapy was regarded as supportive
work rather than CBT-P. A randomly selected sub-
sample of 36 tapes was sent to external expert raters ;
their ratings showed excellent agreement with the
internal raters (Garety et al. 2008).
All therapists also used the R-CTPAS to provide
self-report assessments of their therapy sessions.
Agreement between tape-rated and self-reported
ratings of R-CTPAS across multiple raters was satis-
factory, with intraclass correlation coeﬃcients for
composite scores ranging from 0.5 to 0.8.
Summary scores of therapy delivery
In the current study, the taped and self-reported
adherence ratings from the R-CTPAS (Rollinson et al.
2008) were used to create a single summary score
for the therapy received by each person treated in
the trial. These were derived from the factor analysis
of the R-CTPAS, described above. The ﬁrst factor,
which we term ‘partial therapy’, comprised engage-
ment and assessment techniques : that is, active
attempts to engage in therapeutic strategies ; the
‘Columbo style ’ (which assesses the degree to which
therapists promote guided discovery) ; and the colla-
borative assessment of psychotic experience and
delusional beliefs. The second factor, termed ‘full
therapy’, comprised active therapy techniques : that is,
relapse prevention interventions ; enhancing self-
regulatory strategies ; developing a personal model
of relapse ; developing a model of psychosis ; work
on reinterpreting the meaning of delusional beliefs
and hallucinations ; and schema work. Both factors
described components of active therapy, and the
ﬁrst factor should not be confused with befriending
(Sensky et al. 2000).
Our intention was to ensure that this overall as-
sessment of therapy techniques was reliable. We used
data from 1019 sessions from 102 participants where
there were suﬃcient R-CTPAS data to be fully rep-
resentative of level of therapy. Thirty-one participants
had signiﬁcant levels of missing individual session
data and were coded in the present analysis as ‘not
known’. There were no signiﬁcant diﬀerences on the
baseline variables of interest between the subsample
analysed and those with missing data. There was a
good spread of sessions across the whole duration of
therapy: 30% of the sessions evaluated came from
block 1 (sessions 1–4), 26% from block 2 (sessions 5–9),
22% from block 3 (sessions 10–14) and 21% from block
4 (sessions 15 and above). Average item scores from all
available sessions were calculated for each participant.
The R-CTPAS manual uses a score of 1 (within a range
fromx7 to+7) to indicate the minimum threshold for
highly competent delivery of individual techniques.
For an individual technique to be considered present
across the course of therapy, the averaged item score
needed to be one or above where self-report data were
available, or to be judged above the competence
threshold in at least three sessions, supported by a
tape. This aimed to reﬂect the deﬁnite presence of a
therapy technique occurring across the course of
therapy, and was deliberately chosen to signify the
unequivocal delivery of high quality interventions.
For full or partial therapy to be considered present,
at least one of the composite active intervention
or engagement and assessment items listed above
needed to be present above this threshold across the
course of therapy. Clients who received less than ﬁve
therapy sessions formed a third, no-therapy, group, as
this number of sessions was regarded as too small for
the delivery of eﬀective CBT-P.
Control condition
TAU consisted of good standard care, delivered ac-
cording to national and local service protocols and
guidelines, including the provision of antipsychotic
medication. The frequency and nature of service con-
tacts was monitored, as were medication regimes.
TAU did not preclude the provision of psychological
interventions by locality teams, although this was
unusual.
Primary outcome measures
The primary outcome variable, relapse, was assessed
by a blind panel evaluation procedure (Craig et al.
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2004; Bebbington et al. 2006). Consensus remission and
relapse ratings were applied to detailed extracts of the
clinical case-notes by paired members of the research
team, using manualized a priori operational deﬁnitions
(Bebbington et al. 2006). The original trial report gives
full details (Garety et al. 2008). Here we present the
data as the total number of months in full remission
separately over the ﬁrst and second years of the trial.
Data on hospital admissions were collected through
the hospital administration systems.
Secondary outcome measures
Secondary outcomes were rated by research assessors
at interview, and again considerable eﬀorts were
made to achieve blind ratings (Garety et al. 2008). The
measures used were the PANSS (APA, 1994) and the
Beck Depression Inventory Second Edition (BDI-II ;
Beck et al. 1996). The PANSS is a 30-item, seven-point
(1–7) rating instrument assessing psychotic symptoms
over the past week. We present results for the PANSS
Total (30 items) and PANSS Positive scores (seven
items). The BDI-II is a self-report, 21-item, four-point
scale (0–3) for the assessment of depression over the
past 2 weeks.
Statistical analysis
All analyses reported in the main trial paper (Garety
et al. 2008) were based on the ITT principle, allowing
for potential biases arising from loss to follow-up
[under the assumption that missing outcomes were
missing at random (MAR) using the terminology of
Little & Rubin (2002)].
All analyses presented in the current paper involve
estimating ITT eﬀects within three classes of par-
ticipant. These three classes (principal strata ; Angrist
et al. 1996 ; Frangakis & Rubin, 2002) are deﬁned by the
potential outcome of participants’ treatment allo-
cation. Stratum 1 (no therapy) comprises participants
who would receive little or no therapy (CBT-P) re-
gardless of their randomized allocation. Stratum 2
(partial therapy) comprises those who received partial
therapy in the CBT-P group, together with those con-
trols who would have received partial therapy if they
had been allocated to the CBT-P condition. Finally,
Stratum 3 (full therapy) comprises those participants
who received full therapy in the CBT-P group, to-
gether with those controls who would have done so,
had they been allocated to CBT-P. These three strata
are only partly identiﬁed: class membership is known
for most participants allocated to CBT-P, but not for
the controls, and the model is correspondingly said
not to be identiﬁed; that is, unique stratum-speciﬁc
treatment (ITT) eﬀects cannot be derived. However,
it is possible to identify empirically baseline covariates
that predict the type of treatment delivered in the
randomized-in participants. Because of randomiza-
tion, these can also be used to predict potential treat-
ment compliance in the randomized group. In the
present study, the best predictors were treatment
centre (location), presence of a carer, in-patient status
and sex of the patient. There was no association
between baseline symptomatology and the type of
therapy received.
We used the predictors as covariates in a latent
class model to predict principal stratum membership.
The same covariates were used in the simultaneously
ﬁtted analysis of covariance (ANCOVA) model
used to estimate the stratum-speciﬁc treatment (ITT)
eﬀects. Model identiﬁcation was further improved
by assuming that the ITT eﬀect in the no-therapy
stratum was zero (i.e. allocation to CBT-P has no
average eﬀect when the participant fails to take up
the oﬀered therapy). This is a so-called exclusion
restriction.
A further reﬁnement is based on the realization
that the probability of participants having missing
outcome data (i.e. loss to follow-up) is likely to be
dependent on stratum membership; the no-therapy
group, for example, would seem less likely to provide
outcome data than those from the other two strata. The
missing data mechanism might still be MAR, but it
might equally be latently ignorable (LI) (Frangakis &
Rubin, 1999). In the LI model, the probability of loss to
follow-up is jointly dependent on stratum member-
ship and the outcome of random allocation, and also
on baseline covariates (the structure of the missing
data model then being analogous to that for the out-
comes). The exclusion restrictions for the missing data
indicator were the same as for the ﬁnal outcomes.
Technical details and illustrations using data from
psychological treatment trials are provided elsewhere
(Dunn et al. 2005 ; Emsley et al. 2010).
All analyses reported in the present paper were
carried out using Mplus version 5.2 (Muthe´n &
Muthe´n, 1998–2009). To avoid local maxima (invalid
estimates), 1000 randomly perturbed sets of starting
values were used. All standard errors were estimated
using bootstrapping (250 replications) (Efron &
Tibshirani, 1993). Note that in none of the analyses
have we allowed for individual therapist eﬀects
(clustering by therapist) ; for technical reasons it would
have not been feasible, assuming instead that these are
subsumed by the centre eﬀects.
Results
In all participants receiving full therapy, the tech-
niques associated with partial therapy were also
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delivered. In every case, at each level of therapy,
multiple techniques were present. Forty-two par-
ticipants had full therapy, and 39 partial therapy. A
further 21 participants had less than ﬁve sessions of
therapy, thus falling into our no-therapy group. It
should be emphasized that partial therapy met the
deﬁnition of highly competent cognitive therapy and
was observed to be accompanied by attempts by the
therapists to deliver the techniques of full therapy
as well. However, in partial therapy such attempts,
by deﬁnition, fell below the predeﬁned threshold
for the identiﬁcation of full therapy.
Table 1 provides information on the demographic
characteristics of the trial participants. Table 2 illus-
trates the distribution of those in the CBT-P group re-
ceiving no therapy, partial therapy and full therapy,
cross-classiﬁed by various baseline factors. Treatment
centre (location) seems to be the best predictor of
therapy received (note, in particular, that 19 of the 42
patients receiving full therapy were from Centre 3).
Table 3 provides information on the two main out-
comes (time in remission and PANSS Total scores) by
treatment arm, separately for the no-therapy, partial
therapy and full therapy subgroups. There are no
obvious patterns, and the full therapy subgroup did
no better than the others. However, using the mean
outcomes for these subgroups in this way cannot
distinguish between eﬀects arising from the treat-
ment of interest and those deriving from treatment-
independent prognosis (confounding or selection
eﬀects). Hence the need for more reﬁned analysis. The
requirement that is missing for the comparison of sub-
group treatment eﬀects is the average outcome in the
respective principal strata in the control (TAU) con-
dition.
We now summarize the analyses based on the
use of principal stratiﬁcation. In Table 4, we provide
estimates of stratum-speciﬁc ITT eﬀects for our four
chosen outcomes, displayed separately for follow-up
at 12 and 24 months. There were very fewmissing data
for the number of months in remission, and we as-
sumed that such missing data as existed were MAR.
Data from research interviews were more likely to be
missing, and we therefore used two separate methods
for dealing with missing data. In the ﬁrst, we assumed
data were MAR. The second analysis assumes missing
outcomes were LI.
Table 4 shows diﬀerences between treatment and
control groups for each of the two principal strata
corresponding to partial and full therapy respectively.
Full treatment brings about nearly six additional
months in remission between induction and the
12-month follow-up (indicated by an ITT eﬀect
with a positive sign) and an additional two months
between the 12- and 24-month assessments. The
Table 1. Demographic characteristics of participants
TAU (n=140) CBT (n=133)
Gender
Male 97 95
Female 43 38
Ethnicity
White 105 88
Black Caribbean 8 14
Black African 14 13
Black other 4 3
Indian 0 5
Other 9 10
Employment
Employed 8 5
Employed part-time 4 2
Voluntary employment 1 7
Unemployed 117 112
Student 8 3
Retired 2 1
Housewife/husband 0 2
Unknown 0 1
Marital status
Single 107 91
Married 8 16
Divorced/separated 21 24
Widowed 1 2
Unknown 3 0
Diagnosis
Schizophrenia 117 117
Schizo-aﬀective disorder 23 12
Delusional disorder 0 4
In hospital ?
In-patient 96 92
Out-patient 44 41
History of violence
No 102 86
Yes 35 42
History of suicide
or self-harm
No 80 81
Yes 55 46
Mean age, years (S.D.) 36.8 (10.9) 39.0 (10.7)
Mean duration of
illness, years (S.D.)
10.1
(8.6, n=135)
10.9
(8.4, n=131)
Mean no. of
admissions (S.D.)
4.4
(4.6, n=130)
4.7
(5.2, n=129)
PANSS Total mean (S.D.) 65.8 (15.8) 63.2 (13.7)
PANSS Positive mean (S.D.) 18.5 (5.3) 17.8 (5.5)
BDI-II mean (S.D.) 20.7
(13.5, n=136)
22.2
(12.2, n=130)
TAU, Treatment as usual ; CBT, cognitive behaviour
therapy ; PANSS, Positive and Negative Syndrome Scale ;
BDI-II, Beck Depression Inventory Second Edition ;
S.D., standard deviation.
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12-month eﬀect is statistically signiﬁcant (at the
5% level). There is a suggestion that the ITT eﬀect
in the partial therapy group may be negative
(detrimental) but the eﬀects are not statistically sig-
niﬁcant.
The results for months in remission are mirrored
in the ﬁndings for PANSS and BDI scores. At
12 months, the full therapy group had a statistically
signiﬁcant 16-point advantage on PANSS Total score
over the control group (an ITT eﬀect with a nega-
tive sign). Under the assumption that missing data
were LI, the PANSS advantage fell to 12 points
and was no longer signiﬁcant. At 24 months, the
advantage was still 11 points (12 under LI as-
sumptions), albeit no longer statistically signiﬁcant.
Again, there is a suggestion that partial therapy
might be detrimental rather than beneﬁcial. Stratum-
speciﬁc ITT eﬀects for the PANSS Positive and
BDI scores were consistent with the above ﬁndings,
although none of the eﬀects were statistically signiﬁ-
cant.
The results in Table 4 indicate that stratum-speciﬁc
ITT eﬀects for the 24-month outcomes were very
similar to those at 12 months. We therefore decided
to reﬁne our analyses by estimating stratum-speciﬁc
ITT eﬀects that were assumed to be common (i.e.
the same) for the ﬁrst and second 12-month periods
of follow-up (see Appendix). The reﬁned ANCOVA
model for the outcomes was now bivariate. This
allows for period-speciﬁc eﬀects of the baseline
covariates and correlations between the residuals of
the outcomes at the two periods, and is an example
of a Seemingly Unrelated Regression (SUR; Cox &
Wermuth, 1996). The rationale was to improve both
precision and statistical power, justiﬁed in the light of
the consistency of eﬀects across measures and periods.
Table 5 records the estimates of the stratum-speciﬁc
ITT eﬀects common to the two periods covered in the
follow-up. Initially, each result is presented three
times (three rows of ITT estimates). The ﬁrst carries no
exclusion restrictions (a relaxation of the assumptions
in the models ﬁtted above). In the second, the no-
therapy group is set to zero (a single pair of exclusion
restrictions, one for the 12-month outcome and
another for 24 months, corresponding to our initial
models). The last analysis includes similar constraints
Table 2. Number of participants receiving each level of cognitive behaviour therapy (CBT)
By location Centre 1 Centre 2 Centre 3 Centre 4 Centre 5 Total
Control group 26 19 35 35 25 140
CBT group
No therapy 2 4 6 2 7 21
Partial therapy 12 8 6 11 2 39
Full therapy 9 1 19 8 5 42
Not known 3 2 3 13 10 31
By carer Has carer Does not have carer
Control group 41 99
CBT group
No therapy 10 11
Partial therapy 11 28
Full therapy 13 29
Not known 12 19
By in-patient status In-patient Out-patient
Control group 96 44
CBT group
No therapy 12 9
Partial therapy 23 16
Full therapy 32 10
Not known 25 6
By sex Male Female
Control group 96 44
CBT group
No therapy 16 5
Partial therapy 25 14
Full therapy 32 10
Not known 23 8
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imposed on both the no-therapy and partial therapy
groups (two pairs of exclusion restrictions). The
introduction of these additional exclusion restrictions
prevents the eﬀect of partial therapy from being
detrimental and is therefore a stringent test of the
eﬀect in the full therapy stratum. This change (and
the relaxation of all restrictions as in the top row)
provides a check on the sensitivity of the estimate of
the eﬀect of full therapy to a diﬀerent set of model
assumptions. As in Table 4, the results are calculated
under diﬀerent assumptions about the distribution of
missing data.
Table 3. Outcomes by level of therapy (mean, S.D., n)
Months in remission PANSS Total
0–12 months 12–24 months Baseline 12 months 24 months
Control group 7.60, 4.47, 137 8.77, 4.56, 132 65.83, 15.76, 140 59.39, 16.61, 113 57.04, 15.96, 109
CBT group
No therapy 5.10, 5.25, 20 8.45, 4.57, 20 63.00, 16.16, 21 56.40, 14.68, 10 52.27, 15.37, 11
Partial therapy 8.39, 3.78, 38 9.68, 3.91, 38 66.15, 12.68, 39 60.13, 14.41, 38 58.94, 14.57, 36
Full therapy 7.57, 4.52, 42 8.60, 4.43, 42 63.50, 13.09, 42 55.97, 13.98, 37 56.27, 11.59, 37
Not known 7.58, 4.39, 31 8.57, 3.77, 30 59.42, 13.79, 31 53.96, 16.26, 26 53.96, 14.79, 25
CBT, Cognitive behaviour therapy ; PANSS, Positive and Negative Syndrome Scale ; S.D., standard deviation.
Table 4. ITT estimates within principal strata, separately for 12- and 24-month outcomes (bootstrapped standard errors in parentheses)
No therapy
(non-compliers) Partial therapy Full therapy
(a) Negligible amounts of missing data (assumed MAR)
Months in remission
0–12 months 0a x1.7 (1.1) +5.6 (2.7)b
12–24 months 0a x2.1 (1.4) +2.1 (2.1)
(b) With missing outcomes assumed to be MAR
PANSS Total score
12 months 0a +6.4 (3.7) x16.4 (6.8)b
24 months 0a +7.5 (4.6) x11.3 (5.9)
PANSS Positive score
12 months 0a +1.8 (1.6) x5.5 (2.8)
24 months 0a +3.4 (2.4) x2.8 (3.3)
BDI score
12 months 0a +2.2 (4.5) x2.8 (4.5)
24 months 0a +2.7 (3.5) x7.4 (4.6)
(c) With missing outcomes assumed to be LI
PANSS Total score
12 months 0a +7.7 (5.0) x11.8 (8.2)
24 months 0a +6.5 (5.1) x12.3 (7.0)
PANSS Positive score
12 months 0a +1.7 (2.2) x3.0 (2.8)
24 months 0a +3.7 (2.4) x2.6 (3.2)
BDI score
12 months 0a +5.7 (5.1) x4.9 (4.3)
24 months 0a +2.5 (3.8) x8.3 (6.3)
ITT, Intention to treat ; MAR, missing at random; PANSS, Positive and Negative Syndrome Scale ; BDI, Beck Depression
Inventory ; LI, latently ignorable.
aModel constraint (exclusion restriction).
b Statistically signiﬁcant (p<0.05) : estimate two or more standard errors from zero.
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We made two further sensitivity checks. The ﬁrst
involved merging the ﬁrst two principal strata into
one (the ITT estimates in rows four and ﬁve). The
second involved allocating those with a missing treat-
ment indicator in the CBT-P arm either to the worst
option (no therapy) or to the best (full therapy).
Overall, the reﬁned analyses based on bivariate out-
comes conﬁrmed the ﬁndings in Table 4. Whatever the
measure used, there was a considerable and signiﬁ-
cant advantage in the full therapy group, and the
suspicion of detriment in those receiving only partial
therapy.
Finally, we return to Table 2. There was a centre
eﬀect in the delivery of treatment : the delivery of full
therapy was more frequently achieved in the rural
county of Norfolk (Centre 3). If our conclusions
concerning the eﬀects of receiving full therapy are
valid, then the direct implication is that the ITT eﬀect
of CBT in Centre 3 (rural Norfolk) would be very
diﬀerent to that in the other centres. We therefore
carried out a more conventional analysis of centre ef-
fects (i.e. testing the Centre 3 by CBT interaction). This
is available from the ﬁrst author. It demonstrated
that the treatment (ITT) eﬀects in Centre 3 were
Table 5. Estimated ITT eﬀects within principal strata common to 12- and 24-month follow-up (bootstrapped standard errors in
parentheses)
(a) Negligible amounts of missing data (assumed MAR)
No therapy (non-compliers) Partial therapy Full therapy
Months in remission x2.8 (1.8) x1.9 (0.5)b +4.9 (1.5)b
0a x1.9 (0.5)b +4.7 (1.7)b
0a 0a +4.4 (2.3)b
No and partial therapy (combined) Full therapy
0a +3.5 (2.6)
x2.3 (0.6)b +4.4 (1.4)b
(Not knownpNo or partial therapy) x2.3 (0.4) +5.2 (1.2)
(Not knownpFull therapy) x2.5 (1.2)b +3.7 (1.6)b
(b) Missing data assumed to be MAR
No therapy (non-compliers) Partial therapy Full therapy
PANSS Total score +9.0 (5.6) +3.6 (3.1) x13.0 (3.6)b
0a +5.2 (3.2) x12.7 (4.1)b
0a 0a x12.2 (4.8)b
PANSS Positive score +3.2 (2.2) +0.6 (1.4) x3.9 (1.7)b
0a +1.2 (1.6) x4.0 (1.9)b
0a 0a x3.6 (2.0)
BDI score x0.5 (4.6) +5.3 (3.8) x8.5 (3.5)b
0a +6.3 (3.4) x8.5 (3.1)b
0a 0a x7.0 (3.7)
No and partial therapy (combined) Full therapy
PANSS Total score 0a x10.8 (5.4)b
+6.0 (2.1)b x11.7 (3.5)b
(Not knownpNo or partial therapy) +5.4 (1.9)b x14.0 (3.2)b
(Not knownpFull therapy) +8.2 (4.3) x9.4 (4.5)b
PANNS Positive score 0a x2.0 (2.8)
+2.0 (1.3) x3.4 (2.2)
(Not knownpNo or partial therapy) +1.7 (0.9) x4.2 (2.1)b
(Not knownpFull therapy) x3.1 (2.5) +2.5 (2.3)
BDI score 0a x6.7 (3.3)b
+3.6 (2.1) x8.1 (3.1)b
(Not knownpNo or partial therapy) +2.5 (1.8) x9.2 (3.2)b
(Not knownpFull therapy) +4.0 (2.4) x6.3 (2.7)b
ITT, Intention to treat ; MAR, missing at random; PANSS, Positive and Negative Syndrome Scale ; BDI, Beck Depression
Inventory.
a Exclusion restriction.
b Statistically signiﬁcant (p<0.05) : estimate two or more standard errors from zero.
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commensurably better in terms of PANSS Total and
BDI scores, but not the PANSS Positive score or
months in remission.
Discussion
This study used a novel approach to estimate the
treatment eﬀects of subgroups of the arm receiving
CBT-P in a large randomized controlled treatment
trial. The approach provides less biased estimates of
the eﬀect size of such subgroups by taking account of
the potential outcomes had such cases been random-
ized to the control group. The study compared three
categories of treatment. Our hypothesis was that the
subgroup that engaged with and received full CBT-P
would have better outcomes than those who received
partial therapy or who dropped out. Our results are
wholly consistent with this hypothesis. Treatment was
eﬀective if, and only if, clients received full therapy.
Gains were large, and both clinically and statistically
signiﬁcant. They were also consistent, applying both
to the number of months recovered and relapse free
(the primary outcome) and to psychotic and depress-
ive symptom outcomes. Participants who received
therapy consisting only of engagement and assess-
ment work did not beneﬁt, and neither did those who
dropped out. There is a suggestion that therapy had a
somewhat deleterious eﬀect on the former group.
This is a novel analysis based on a development
of the methods of Complier-Average Causal Eﬀect
(CACE) estimation (Angrist et al. 1996 ; Frangakis
& Rubin, 2002). CASE estimation has been applied
previously to RCTs in psychiatry (Dunn et al. 2003 ;
Horvitz-Lennon et al. 2005 ; Bellamy et al. 2007 ; Serfaty
et al. 2009). The analysis is dependent on modelling
that aims a priori to circumvent the biased estimates of
treatment eﬀects obtained by traditional per protocol
approaches to analysis. In applying this technique,
we have arrived at an estimate strikingly diﬀerent
from the overall ITT result we reported previously,
which showed no eﬀect of CBT-P beyond reducing
depression at 24 months. Moreover, the modelled
eﬀect is not apparent from simple observation of the
mean eﬀects of subgroups within the treated arm
alone (Table 3). Without a proper understanding of the
assumptions underpinning estimations of treatment
eﬀects in randomized trials, this may seem counter-
intuitive. We must, however, take account of the fact
that simple descriptions of mean eﬀects in subgroups
of a single arm of a trial (the treatment arm) are in fact
highly biased estimates of treatment eﬀects. Such de-
scriptive statistics do not take account of biases due to
dropout, and to the putative eﬀects if those random-
ized to treatment had instead been randomized to
control. The modelling used here has been developed
speciﬁcally to overcome such biases, and is described
elsewhere in specialist publications (Frangakis &
Rubin, 1999, 2002 ; Dunn et al. 2005 ; Emsley et al. 2010).
The approach has application to any situation where
heterogeneity in treatment response is analysed in
terms of subgroups deﬁned by post-randomization
explanatory variables. Examples include medication
adherence, therapeutic alliance and intermediate bio-
markers such as immune response.
The trial was designed a priori to study the eﬀects of
diﬀering levels of therapy delivery. We used detailed
observations of adherence and competence to identify
those who received full CBT-P. Only 40% of partici-
pants did so. This raises the question of why so few
received full therapy. CBT-P is complex, and its eﬀec-
tive delivery depends on the interaction between
therapist and patient, and hence on two types of fac-
tors : those relating to the patient (readiness and will-
ingness to engage, the nature of symptoms, awareness,
levels of distress) and those relating to the therapist
(ability, training, supervision, adherence and com-
petence). We ensured that the therapists in the trial
were trained to the highest standards, and this was
supported by our detailed monitoring of therapy
sessions. Despite this, they were able to deliver full
therapy only to a minority. This might therefore be
the result of patient attributes in this sample, although
we must emphasize that there were no baseline
diﬀerences in symptoms. Although people with psy-
chosis have well-known problems with engagement
in therapeutic relationships, the techniques of CBT-P
have been speciﬁcally designed to minimize them.
Nevertheless, in a substantial minority in the present
study, therapists were not able to move much be-
yond maintaining engagement and working colla-
boratively with clients to make sense of their
problems. It would have been interesting to relate the
characteristics of the CBT-P received with the strength
of the therapeutic alliance and to look at their joint
relationship with the eﬀects of therapy. However, the
statistical methods required to undertake this work
are in their infancy (Dunn & Bentall, 2007 ; Emsley
et al. 2010).
The superior delivery of therapy and better treat-
ment eﬀects in Norfolk are noteworthy. The diﬃcult-
ies of delivering complex interventions in inner
city areas are well known to clinicians, and might be
attributed variously to low levels of social support,
high levels of deprivation, and relative residential
instability. Such contextual disadvantages remain a
therapeutic challenge.
Consistent attempts were made to deliver more
active cognitive and behavioural techniques to all
clients, but with many it was impossible to achieve
the level necessary for the a priori deﬁnition of full
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therapy. There are many possible reasons for this,
some of which may be especially characteristic of
unselected, recently relapsed groups. Despite initial
willingness, after a few weeks some patients no longer
wanted to receive therapy. Some had symptoms, but
were not distressed by them, some had responded to
the reinstitution of medication (this was not a medi-
cation-resistant sample, indeed many relapses seemed
to follow discontinuation of medication) and no longer
saw the point of a psychological treatment. Some
simply lacked interest in working with a therapist, and
others had limited awareness of their problems.
Despite such diﬃculties, our therapists managed to
keep these clients engaged in therapy. We had clear
observational evidence of therapists establishing a
basic working cognitive behavioural relationship,
systematically carrying out assessment, and promot-
ing collaborative guided discovery in a highly skilled
manner. However, it must be emphasized that, in this
trial, persistence was sometimes associated with a
worsening of symptoms. This is an important obser-
vation, with implications for clinical practice. We con-
clude that if therapists have not managed to move into
the active phase of therapy within a circumscribed
period, it may not be worth persisting, although clini-
cal experience backs the option of a later return to
therapy. Only clients with whom therapists can de-
liver a substantial amount of active therapy seem to
beneﬁt : future work should aim to identify them.
In summary, this analysis shows clearly that CBT-P
has widespread and beneﬁcial eﬀects when delivered
as intended in a group of relapse-prone patients.
These eﬀects apply to our original primary and
secondary outcomes, of relapse prevention and
symptomatic improvement. CBT-P is therefore clearly
a useful and eﬀective intervention. However, our
results also indicate that those clients whom therapists
cannot engage in substantial active therapy may not
beneﬁt ; at best it is not cost-eﬀective to continue
therapy under such circumstances.
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Appendix : Example of Mplus input ﬁle (modelling 12- and 24-month PANSS scores)
TITLE : PRP Therapy – Principal Stratiﬁcation
DATA:
FILE IS ‘TherapyPredictors.dat ’ ;
VARIABLE:
NAMES ARE r1 r2 r3 r4 carer sex outpat treat ! r1 to r4 are binary dummies indicating treatment centre
c1 c2 c3 pan0 pan12 resp12 pan24 resp24 ; ! resp12 and resp24 are missing value indicators
CLASSES c(3) ;
TRAINING c1 c2 c3 ; ! binary dummies indicating compliance status
CATEGORICAL resp12 resp24 ;
USEVARIABLES treat sex outpat r1 r2 r3 r4 r5
pan0 pan12 resp12 pan24 resp24
c1 c2 c3 carer resp12 resp24 ;
MISSING
pan12 (999) pan24 (999)
ANALYSIS :
TYPE=MIXTURE;
ESTIMATOR=ML;
STARTS=1000 20 ;
BOOTSTRAP=250 ;
MODEL:
%OVERALL%
PAN12 ON treat carer r1 r2 r3 r4 pan0 sex outpat ;
PAN24 ON treat carer r1 r2 r3 r4 pan0 sex outpat ;
pan12 WITH pan24 ;
resp12 ON treat carer r1 r2 r3 r4 pan0 sex outpat ;
resp24 ON treat carer r1 r2 r3 r4 pan0 sex outpat ;
C#1 ON carer r1 r2 r3 r4 PAN0 sex outpat ;
C#2 ON carer r1 r2 r3 r4 PAN0 sex outpat ;
%C#1% ! No therapy
[pan12 pan24 resp12$1 resp24$1] ;
pan12 pan24 (3) ;
pan12 ON treat@0 ;
pan24 ON treat@0 ;
resp12 ON treat@0 ;
resp24 ON treat@0 ;
%C#2% ! Partial therapy
[pan12 pan24 resp12$1 resp24$1] ;
pan12 pan24 (4) ;
pan12 ON treat*0 (1) ;
pan24 ON treat*0 (1) ;
resp12 ON treat*0 (6) ;
resp24 ON treat*0 (6) ;
%C#3% ! Full therapy
[pan12 pan24 resp12$1 resp24$1] ;
pan12 pan24 (5) ;
pan12 ON treat*0 (2) ;
pan24 ON treat*0 (2) ;
resp12 ON treat*0 (7) ;
resp24 ON treat*0 (7) ;
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